Odyssey Health, Inc.

Odyssey Health, Inc. is a publicly held company that acquires and develops medical products. The company focuses on technologies with a technological advantage, superior clinical utility, and substantial market opportunities globally. Odyssey Health, Inc. operates through its subsidiaries, Odyssey Medical Devices, Inc. and Odyssey Group International Australia, Pty Ltd. Its business model involves developing or acquiring medical-related products, engaging third parties for development and manufacturing, and then distributing these products through various channels, including third parties. The company currently has two technologies in the research and development stage: the CardioMap heart monitoring and screening device and the Save-A-Life choking rescue device. As of now, none of its product candidates have received regulatory clearance or approval for commercial sale. Odyssey Health, Inc. plans to acquire additional technologies and assets to become a trans-disciplinary product development company, involved in developing and commercializing products and technologies applicable across various medical markets. The company was formed as a Nevada corporation in March 2014, and its shares of common stock are listed on the OTCQB Marketplace.